Top compounds associated with response to RILPL1


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.002
mRNA I-BET151 CTRPv2 pan-cancer AAC -0.12 0.002
mRNA EHT 1864 GDSC1000 pan-cancer AAC 0.12 0.002
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.002
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.13 0.003
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.16 0.003
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.12 0.003
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.004
mRNA pac-1 CTRPv2 pan-cancer AAC -0.13 0.004
mRNA PD-0332991 GDSC1000 pan-cancer AAC 0.11 0.004
Download CSV